D.J. St. Germain’s iShares Biotechnology ETF IBB Stock Holding History

D.J. St. Germain’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Hold	1,170	–	–	0.01%	295
2026 Q1	$198K	Hold	1,170	–	–	0.01%	299
2025 Q4	$197K	Hold	1,170	–	–	0.01%	304
2025 Q3	$169K	Hold	1,170	–	–	0.01%	324
2025 Q2	$148K	Hold	1,170	–	–	0.01%	333
2025 Q1	$150K	Hold	1,170	–	–	0.01%	290
2024 Q4	$155K	Sell	1,170 -15	-1%	-$2.11K	0.01%	308
2024 Q3	$173K	Hold	1,185	–	–	0.01%	282
2024 Q2	$163K	Hold	1,185	–	–	0.01%	284
2024 Q1	$163K	Sell	1,185 -150	-11%	-$20.5K	0.01%	281
2023 Q4	$181K	Hold	1,335	–	–	0.01%	269
2023 Q3	$163K	Buy	1,335 +165	+14%	+$21K	0.01%	259
2023 Q2	$149K	Buy	+1,170	New	+$152K	0.01%	264
2021 Q1	–	Sell	-1,695	Closed	-$257K	–	232
2020 Q4	$257K	Hold	1,695	–	–	0.02%	208
2020 Q3	$230K	Sell	1,695 -597	-26%	-$81K	0.02%	198
2020 Q2	$313K	Hold	2,292	–	–	0.03%	174
2020 Q1	$247K	Hold	2,292	–	–	0.02%	189
2019 Q4	$276K	Sell	2,292 -60	-3%	-$6.69K	0.02%	192
2019 Q3	$234K	Hold	2,352	–	–	0.03%	173
2019 Q2	$257K	Buy	+2,352	New	+$250K	0.03%	165
2015 Q2	–	Sell	-2,145	Closed	-$246K	–	106
2015 Q1	$246K	Hold	2,145	–	–	0.04%	93
2014 Q4	$217K	Sell	2,145 -225	-9%	-$21.9K	0.03%	102
2014 Q3	$216K	Buy	+2,370	New	+$208K	0.03%	99
2014 Q1	–	Sell	-118,452	Closed	-$8.96M	–	105
2013 Q4	$8.96M	Sell	118,452 -3,207	-3%	-$228K	1.31%	34
2013 Q3	$8.5M	Sell	121,659 -29,439	-19%	-$1.93M	1.37%	33
2013 Q2	$8.76M	Buy	+151,098	New	+$8.73M	1.45%	34

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

D.J. St. Germain's IBB Position: Q2 2026 in Review

D.J. St. Germain held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,170 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #295.

D.J. St. Germain first reported a position in IBB in Q2 2013 and has held it in 26 quarters since. The position peaked at $8.96M in Q4 2013. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

D.J. St. Germain held 1,170 shares of iShares Biotechnology ETF worth $223K as of Q2 2026.
D.J. St. Germain left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of D.J. St. Germain's portfolio in Q2 2026, its #295 holding.
D.J. St. Germain first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 26 quarters since.
D.J. St. Germain's iShares Biotechnology ETF position peaked at $8.96M in Q4 2013.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.